Lawrence Strawbridge, MD
Urology · Anchorage, AKNPI 1467405324
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in AK, where the typical reported total is $2,491.
Across 17 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$54
- Johnson & Johnson$52
- Sun Pharmaceutical Industries Inc.$49
- AstraZeneca$33
- Boston Scientific$20
- Astellas Pharma US Inc$18
- plus $73 from 6 others
What the payments were for
- Food & beverage$29599%
- Education$41%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 2 | $54 |
| Johnson & Johnson | 4 | $52 |
| Sun Pharmaceutical Industries Inc. | 1 | $49 |
| AstraZeneca | 2 | $33 |
| Boston Scientific | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Seagen Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
| Bayer | 1 | $14 |
| AbbVie | 1 | $13 |
| Tolmar Pharmaceuticals, Inc. | 1 | $12 |
| Travere Therapeutics, Inc. | 1 | $4 |
How this compares
$299 in reported general payments places this provider in the 20th percentile of 28 urology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Anchorage
- Joshua LoganAnchorage$16K
- William ClarkAnchorage$9K
- Elysia SpencerAnchorage$8K
- Andre GodetAnchorage$5K
- Bryan WilsonAnchorage$4K
- Mariam MillerAnchorage$4K
- Sarah BeebeAnchorage$3K
- Zachary PoseyAnchorage$2K
- Nancy GillcristAnchorage$2K
- Paul FerucciAnchorage$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.